Cargando…
DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle
Progress in whole-genome sequencing using short-read (e.g., <150 bp), next-generation sequencing technologies has reinvigorated interest in high-resolution physical mapping to fill technical gaps that are not well addressed by sequencing. Here, we report two technical advances in DNA nanotechnolo...
Autores principales: | , , , , , , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698298/ https://www.ncbi.nlm.nih.gov/pubmed/29162844 http://dx.doi.org/10.1038/s41467-017-01891-9 |
_version_ | 1783280735283576832 |
---|---|
author | Mikheikin, Andrey Olsen, Anita Leslie, Kevin Russell-Pavier, Freddie Yacoot, Andrew Picco, Loren Payton, Oliver Toor, Amir Chesney, Alden Gimzewski, James K. Mishra, Bud Reed, Jason |
author_facet | Mikheikin, Andrey Olsen, Anita Leslie, Kevin Russell-Pavier, Freddie Yacoot, Andrew Picco, Loren Payton, Oliver Toor, Amir Chesney, Alden Gimzewski, James K. Mishra, Bud Reed, Jason |
author_sort | Mikheikin, Andrey |
collection | PubMed |
description | Progress in whole-genome sequencing using short-read (e.g., <150 bp), next-generation sequencing technologies has reinvigorated interest in high-resolution physical mapping to fill technical gaps that are not well addressed by sequencing. Here, we report two technical advances in DNA nanotechnology and single-molecule genomics: (1) we describe a labeling technique (CRISPR-Cas9 nanoparticles) for high-speed AFM-based physical mapping of DNA and (2) the first successful demonstration of using DVD optics to image DNA molecules with high-speed AFM. As a proof of principle, we used this new “nanomapping” method to detect and map precisely BCL2–IGH translocations present in lymph node biopsies of follicular lymphoma patents. This HS-AFM “nanomapping” technique can be complementary to both sequencing and other physical mapping approaches. |
format | Online Article Text |
id | pubmed-5698298 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2017 |
publisher | Nature Publishing Group UK |
record_format | MEDLINE/PubMed |
spelling | pubmed-56982982017-11-24 DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle Mikheikin, Andrey Olsen, Anita Leslie, Kevin Russell-Pavier, Freddie Yacoot, Andrew Picco, Loren Payton, Oliver Toor, Amir Chesney, Alden Gimzewski, James K. Mishra, Bud Reed, Jason Nat Commun Article Progress in whole-genome sequencing using short-read (e.g., <150 bp), next-generation sequencing technologies has reinvigorated interest in high-resolution physical mapping to fill technical gaps that are not well addressed by sequencing. Here, we report two technical advances in DNA nanotechnology and single-molecule genomics: (1) we describe a labeling technique (CRISPR-Cas9 nanoparticles) for high-speed AFM-based physical mapping of DNA and (2) the first successful demonstration of using DVD optics to image DNA molecules with high-speed AFM. As a proof of principle, we used this new “nanomapping” method to detect and map precisely BCL2–IGH translocations present in lymph node biopsies of follicular lymphoma patents. This HS-AFM “nanomapping” technique can be complementary to both sequencing and other physical mapping approaches. Nature Publishing Group UK 2017-11-21 /pmc/articles/PMC5698298/ /pubmed/29162844 http://dx.doi.org/10.1038/s41467-017-01891-9 Text en © The Author(s) 2017 Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Article Mikheikin, Andrey Olsen, Anita Leslie, Kevin Russell-Pavier, Freddie Yacoot, Andrew Picco, Loren Payton, Oliver Toor, Amir Chesney, Alden Gimzewski, James K. Mishra, Bud Reed, Jason DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle |
title | DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle |
title_full | DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle |
title_fullStr | DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle |
title_full_unstemmed | DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle |
title_short | DNA nanomapping using CRISPR-Cas9 as a programmable nanoparticle |
title_sort | dna nanomapping using crispr-cas9 as a programmable nanoparticle |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5698298/ https://www.ncbi.nlm.nih.gov/pubmed/29162844 http://dx.doi.org/10.1038/s41467-017-01891-9 |
work_keys_str_mv | AT mikheikinandrey dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT olsenanita dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT lesliekevin dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT russellpavierfreddie dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT yacootandrew dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT piccoloren dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT paytonoliver dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT tooramir dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT chesneyalden dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT gimzewskijamesk dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT mishrabud dnananomappingusingcrisprcas9asaprogrammablenanoparticle AT reedjason dnananomappingusingcrisprcas9asaprogrammablenanoparticle |